TY - GEN 
AU - Sanabria, Jose †
AU - Garzón,Vivian †
AU - Pacheco, Tatiana
AU - Avila, Maria-Paula
AU - Garcia, Julio-Cesar
AU - Jaimes, Diego
AU - Torres, Angela
AU - Bustos, Rosa-Helena
AU - Escobar-Perez, Javier
AU - Abril, Deisy
PY - 2021
SN - 1999-4923
UR - http://hdl.handle.net/10818/54185
AB - In recent decades, antimicrobial resistance (AMR) has led to an increased use of therapeutic alternatives. Among these options, colistin continues to be an option for the treatment of multiresistant (MDR) Gram-negative bacterial infections. However,...
LA - eng
PB - Pharmaceutics
KW - Therapeutic drug monitoring (TDM)
KW - Colistin
KW - Multi-Drug Resistance bacteria
KW - Gram-Negative bacteria
TI - Estimation of the Difference in Colistin Plasma Levels in Critically Ill Patients with Favorable or Unfavorable Clinical Outcomes
DO - 10.3390/pharmaceutics13101630
ER -